Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

6.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remuscularizing the Failing Human Heart.

The New England journal of medicine·2026
Same author

eIF4G2-mediated selective translation of chromatin regulators safeguards adult intestinal stem cell identity and differentiation.

Cell stem cell·2026
Same author

Author Correction: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.

Nature·2026
Same author

Genome-wide CRISPRi screen identifies basigin loss as protective in cardiac hypoxia.

bioRxiv : the preprint server for biology·2026
Same author

Maintenance of Energy Metabolism Is an Integral Part of Plakophilin-2 and Desmosome Functions.

JACC. Basic to translational science·2025
Same author

The oligogenic inheritance test GCOD detects risk genes and their interactions in congenital heart defects.

Genome research·2025

Related Experiment Video

Updated: Apr 1, 2026

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors
09:45

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors

Published on: January 1, 2017

11.6K

Practical Integration-Free Episomal Methods for Generating Human Induced Pluripotent Stem Cells.

Cody Kime1,2,3, Tim A Rand1,2, Kathryn N Ivey1,2,4

  • 1Gladstone Institute of Cardiovascular Disease, San Francisco, California.

Current Protocols in Human Genetics
|October 7, 2015
PubMed
Summary
This summary is machine-generated.

Induced pluripotent stem (iPS) cell technology offers potential for therapies and disease modeling. New methods generate safer, high-quality iPS cells using non-integrating episomal plasmids for enhanced reprogramming efficiency.

Keywords:
episomalhumaninduced pluripotent stem cellreprogramming

More Related Videos

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

13.4K
Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids
10:52

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids

Published on: June 5, 2015

13.7K

Related Experiment Videos

Last Updated: Apr 1, 2026

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors
09:45

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors

Published on: January 1, 2017

11.6K
Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

13.4K
Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids
10:52

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids

Published on: June 5, 2015

13.7K

Area of Science:

  • Biomedicine and regenerative medicine
  • Stem cell biology
  • Genomic reprogramming technologies

Background:

  • Induced pluripotent stem (iPS) cells, similar to embryonic stem (ES) cells, have transformed biomedicine and research.
  • Early iPS cell generation involved viral vectors, posing safety concerns due to genomic integration.
  • Recent advancements focus on safer, more efficient methods for generating high-quality iPS cells.

Purpose of the Study:

  • To describe optimized methods for generating non-integrating human induced pluripotent stem (hiPS) cells.
  • To highlight techniques that improve reprogramming efficiency and cell quality.
  • To provide a practical guide for researchers utilizing episomal plasmid-based reprogramming.

Main Methods:

  • Utilizing nucleofection for the delivery of episomal reprogramming plasmids into somatic cells.
  • Employing a combination of three key episomal reprogramming factor vectors.
  • Incorporating an accessory vector expressing EBNA1 to enhance reprogramming efficacy.

Main Results:

  • Demonstrated successful generation of non-integrating iPS cells using nucleofection and episomal plasmids.
  • Achieved increased reprogramming efficiency compared to previous methods.
  • Produced high-quality iPS cells suitable for therapeutic and research applications.

Conclusions:

  • Non-integrating episomal plasmid-based reprogramming offers a safer and more efficient alternative for iPS cell generation.
  • Optimized methods enhance the potential of iPS cell technology for cell-based therapies and disease modeling.
  • Further development of these techniques will advance the clinical translation of iPS cell applications.